Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Verastem
Pharma
FDA approves Verastem's combo for rare form of ovarian cancer
Verastem has gained its first FDA approval, winning an accelerated nod for the combo therapy to treat a rare form of ovarian cancer.
Kevin Dunleavy
May 9, 2025 10:42am
Verastem sets first awareness day for rare ovarian cancer
Sep 3, 2024 3:20pm
Verastem survey shows toll rare cancer takes on well-being
Mar 18, 2024 12:46pm
Verastem campaign highlights new meds for rare ovarian cancer
Mar 16, 2023 7:20am
FDA probes TG Therapeutics' Ukoniq for potential death risks
Feb 7, 2022 9:53am
Taiho, Otsuka, Chugai, Biocon and Mark Alles—FiercePharmaAsia
Jan 10, 2020 10:59am
